|
Atlasītas 5094 zāles
...
|
...
|
Zāļu nosaukums 
|
Zāļu forma | Stiprums/koncentrācija |
Aktīvās vielas
|
ATĶ kods
|
Maks. cenu diapazons,
(€ ar PVN)
|
Reģistrācijas
numurs
|
Reģistrācijas apliecības īpašnieks, valsts
|
|
Rx |
Abacavir/Lamivudine Mylan Pharma 600 mg/300 mg apvalkotās tabletes |
Apvalkotā tablete | 600 mg/300 mg | Abacavirum, Lamivudinum  |
J05AR02
|
|
17-0218 |
Mylan Ireland Limited, Īrija |
 |
Rx KZSR |
Accupro 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg | Quinaprili hydrochloridum |
C09AA06
|
4,97 |
99-0548 |
Pfizer Europe MA EEIG, Beļģija |
|
Rx KZSR |
Accupro 20 mg apvalkotās tabletes |
Apvalkotā tablete | 20 mg | Quinaprili hydrochloridum |
C09AA06
|
6,16 |
99-0549 |
Pfizer Europe MA EEIG, Beļģija |
 |
Rx |
Aceclofenac Rivopharm 100 mg apvalkotās tabletes |
Apvalkotā tablete | 100 mg | Aceclofenacum |
M01AB16
|
6,47–16,42 |
15-0046 |
Rivopharm Ltd., Īrija |
|
OTC |
Aceterin express 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg | Cetirizini dihydrochloridum |
R06AE07
|
5,77 |
03-0256 |
Sandoz d.d., Slovēnija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 40 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/001 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 40 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/002 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/003 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/004 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 40 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/036 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/037 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 FlexPen |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/033 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 FlexPen |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/034 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 FlexPen |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/035 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 InnoLet |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/030 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 InnoLet |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/031 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 InnoLet |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/032 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/011 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/012 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 30 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/013 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 40 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/014 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 40 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/015 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 40 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/016 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 50 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/017 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 50 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/018 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actraphane 50 Penfill |
Suspensija injekcijām | 100 SV/ml | Insulinum humanum |
A10AD01
|
|
EU/1/02/229/019 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 40 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/001 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 40 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/002 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/003 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/004 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 40 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/016 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/017 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid FlexPen |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/013 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid FlexPen |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/014 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid FlexPen |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/015 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid InnoLet |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/011 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid InnoLet |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/012 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid Penfill |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/005 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid Penfill |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/006 |
Novo Nordisk A/S, Dānija |
|
Rx |
Actrapid Penfill |
Šķīdums injekcijām | 100 SV/ml | Insulinum humanum |
A10AB01
|
|
EU/1/02/230/007 |
Novo Nordisk A/S, Dānija |
|
Rx |
Adaptol 300 mg cietās kapsulas |
Kapsula, cietā | 300 mg | Mebicarum |
N05BX
|
8,93 |
03-0001 |
Olainfarm, AS, Latvija |
|
Rx |
Adaptol 300 mg tabletes |
Tablete | 300 mg | Mebicarum |
N05BX
|
|
98-0373 |
Olainfarm, AS, Latvija |
|
Rx |
Adaptol 500 mg tabletes |
Tablete | 500 mg | Mebicarum |
N05BX
|
11,91 |
03-0002 |
Olainfarm, AS, Latvija |
|
Rx |
Adempas |
Apvalkotā tablete | 0,5 mg | Riociguatum |
C02KX05
|
1581,23 |
EU/1/13/907/001 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 0,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/002 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 0,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/003 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1 mg | Riociguatum |
C02KX05
|
1581,23 |
EU/1/13/907/004 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/005 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/006 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1,5 mg | Riociguatum |
C02KX05
|
1581,23 |
EU/1/13/907/007 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/008 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/009 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2 mg | Riociguatum |
C02KX05
|
1581,23 |
EU/1/13/907/010 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/011 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/012 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2,5 mg | Riociguatum |
C02KX05
|
1581,23 |
EU/1/13/907/013 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/014 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/015 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 0,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/016 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/017 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 1,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/018 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/019 |
Bayer AG, Vācija |
|
Rx |
Adempas |
Apvalkotā tablete | 2,5 mg | Riociguatum |
C02KX05
|
|
EU/1/13/907/020 |
Bayer AG, Vācija |
 |
Rx |
Adepend 50 mg apvalkotās tabletes |
Apvalkotā tablete | 50 mg | Naltrexoni hydrochloridum |
N07BB04
|
|
12-0298 |
Norameda UAB, Lietuva |
|
Rx |
Adjupanrix |
Emulsija un suspensija injekciju emulsijas pagatavošanai | 3,75 μg | Vaccinum influenzae pandemicae (H5N1) (virion fissum, inactivatum, cum adjuvante) |
J07BB02
|
|
EU/1/09/578/001 |
GlaxoSmithKline Biologicals S.A., Beļģija |
|
Rx |
Adrenaline Sopharma 1 mg/ml šķīdums injekcijām |
Šķīdums injekcijām | 1 mg/ml | Epinephrinum |
C01CA24
|
8,48–68,54 |
05-0362 |
Sopharma AD, Bulgārija |
|
Rx |
Aerivio Spiromax |
Inhalācijas pulveris | 50 µg/500 µg | Salmeterolum, Fluticasoni propionas |
R03AK06
|
|
EU/1/16/1122/001 |
Teva B.V., Nīderlande |
|
Rx |
Aerivio Spiromax |
Inhalācijas pulveris | 50 µg/500 µg | Salmeterolum, Fluticasoni propionas |
R03AK06
|
|
EU/1/16/1122/002 |
Teva B.V., Nīderlande |
|
Rx |
Agodeprin 25 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg | Agomelatinum |
N06AX22
|
|
18-0103 |
Sandoz d.d., Slovēnija |
|
Rx |
Agomelatine Anpharm 25 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg | Agomelatinum |
N06AX22
|
|
18-0126 |
ANPHARM Przedsiebiorstwo Farmaceutyczne S.A., Polija |
|
OTC |
Airapy 100%, medicīniskā gāze, saspiesta |
Medicīniskā gāze, saspiesta | 100% | Aer medicinalis |
V03AN05
|
|
07-0263 |
Linde Gas, Zviedrija |
|
Rx KZSR |
Airbufo Forspiro 160 mikrogrami/4,5 mikrogrami/inhalācijā, inhalācijas pulveris, dozēts |
Inhalācijas pulveris, dozēts | 160 μg/4,5 μg/inhalācijā | Budesonidum, Formoteroli fumaras dihydricus |
R03AK07
|
30,11 |
18-0087 |
Sandoz d.d., Slovēnija |
|
Rx |
Airexar Spiromax |
Inhalācijas pulveris | 50 µg/500 µg | Salmeteroli xinafoas, Fluticasoni propionas |
R03AK06
|
|
EU/1/16/1123/001 |
Teva B.V., Nīderlande |
|
Rx |
Airexar Spiromax |
Inhalācijas pulveris | 50 µg/500 µg | Salmeteroli xinafoas, Fluticasoni propionas |
R03AK06
|
|
EU/1/16/1123/002 |
Teva B.V., Nīderlande |
|
Rx KZSR |
AirFluSal Forspiro 50/250 mikrogrami/devā pulveris inhalācijām, dozēts |
Inhalācijas pulveris, dozēts | 50/250 μg/devā | Salmeterolum, Fluticasoni propionas |
R03AK06
|
28,54 |
14-0224 |
Sandoz d.d., Slovēnija |
|
Rx KZSR |
AirFluSal Forspiro 50/500 mikrogrami/devā pulveris inhalācijām, dozēts |
Inhalācijas pulveris, dozēts | 50/500 μg/dose | Salmeterolum, Fluticasoni propionas |
R03AK06
|
37,61 |
14-0225 |
Sandoz d.d., Slovēnija |
|
Rx |
Aktiprol 100 mg tabletes |
Tablete | 100 mg | Amisulpridum |
N05AL05
|
18,12 |
15-0121 |
Medochemie Ltd., Kipra |
|
Rx KZSR |
Aktiprol 200 mg tabletes |
Tablete | 200 mg | Amisulpridum |
N05AL05
|
20,92 |
15-0122 |
Medochemie Ltd., Kipra |
|
Rx KZS |
Aktiprol 200 mg tabletes |
Tablete | 200 mg | Amisulpridum |
N05AL05
|
20,90 |
I000937 |
Medochemie Ltd., Kipra |
|
Rx KZS |
Aktiprol 200 mg tabletes |
Tablete | 200 mg | Amisulpridum |
N05AL05
|
18,77 |
I000978 |
Medochemie Ltd., Kipra |
|
Rx KZSR |
Aktiprol 400 mg tabletes |
Tablete | 400 mg | Amisulpridum |
N05AL05
|
31,71 |
15-0123 |
Medochemie Ltd., Kipra |
|
Rx KZSR |
Aktiprol 50 mg tabletes |
Tablete | 50 mg | Amisulpridum |
N05AL05
|
11,55 |
15-0120 |
Medochemie Ltd., Kipra |
|
Rx |
Aleptolan 1 mg apvalkotās tabletes |
Apvalkotā tablete | 1 mg | Risperidonum |
N05AX08
|
14,50 |
07-0055 |
G.L. Pharma GmbH, Austrija |
|
Rx |
Aleptolan 2 mg apvalkotās tabletes |
Apvalkotā tablete | 2 mg | Risperidonum |
N05AX08
|
27,48 |
07-0056 |
G.L. Pharma GmbH, Austrija |
|
Rx |
Aleptolan 3 mg apvalkotās tabletes |
Apvalkotā tablete | 3 mg | Risperidonum |
N05AX08
|
40,89 |
07-0057 |
G.L. Pharma GmbH, Austrija |
|
Rx |
Aleptolan 4 mg apvalkotās tabletes |
Apvalkotā tablete | 4 mg | Risperidonum |
N05AX08
|
53,27 |
07-0058 |
G.L. Pharma GmbH, Austrija |
|
Rx |
Alerpalux 1 mg/ml acu pilieni, šķīdums |
Acu pilieni, šķīdums | 1 mg/ml | Olopatadinum |
S01GX09
|
|
13-0243 |
PharmaSwiss Ceska republika s.r.o., Čehija |
|
OTC |
Alka-Prim 330 mg putojošās tabletes |
Putojošā tablete | 330 mg | Acidum acetylsalicylicum |
N02BA01
|
4,70 |
97-0443 |
Pharmaceutical Works Polpharma SA, Polija |
|
Rx |
Allopurinol Accord 100 mg tabletes |
Tablete | 100 mg | Allopurinolum |
M04AA01
|
|
19-0081 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Allopurinol Accord 300 mg tabletes |
Tablete | 300 mg | Allopurinolum |
M04AA01
|
|
19-0082 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Allopurinol EG 100 mg tabletes |
Tablete | 100 mg | Allopurinolum |
M04AA01
|
3,61 |
I000290 |
EG LABO - Laboratoires EuroGenerics, Francija |
|
Rx |
Allopurinol EG 300 mg tabletes |
Tablete | 300 mg | Allopurinolum |
M04AA01
|
5,57 |
I000291 |
EG LABO - Laboratoires EuroGenerics, Francija |
|
Rx |
Allopurinol Nycomed 100 mg tabletes |
Tablete | 100 mg | Allopurinolum |
M04AA01
|
6,47 |
99-0670 |
Takeda Pharma A/S, Dānija |
|
Rx |
Allopurinol Nycomed 300 mg tabletes |
Tablete | 300 mg | Allopurinolum |
M04AA01
|
9,99 |
93-0442 |
Takeda Pharma A/S, Dānija |
|
Rx |
Allopurinol Sandoz 100 mg tabletes |
Tablete | 100 mg | Allopurinolum |
M04AA01
|
5,99 |
16-0126 |
Sandoz d.d., Slovēnija |
|
Rx |
Allopurinol Sandoz 300 mg tabletes |
Tablete | 300 mg | Allopurinolum |
M04AA01
|
16,99 |
16-0127 |
Sandoz d.d., Slovēnija |
|
Rx |
Almotriptan Zentiva 12,5 mg apvalkotās tabletes |
Apvalkotā tablete | 12,5 mg | Almotriptani malas |
N02CC05
|
16,81 |
12-0101 |
Zentiva, k.s., Čehija |
|
Rx |
Alpha D3 0,25 mikrogrami mīkstās kapsulas |
Kapsula, mīkstā | 0,25 mikrogrami | Alfacalcidolum |
A11CC03
|
|
I000538 |
Teva Gyogyszergyar Zrt., Ungārija |
|
Rx |
Alpha D3 0,5 µg mīkstās kapsulas |
Kapsula, mīkstā | 0,5 mikrogrami | Alfacalcidolum |
A11CC03
|
20,04 |
I001125 |
Teva Pharmaceuticals S.R.L, Rumānija |
|
Rx KZS |
Alpha D3-Teva 0,25 mikrogrami mīkstās kapsulas |
Kapsula, mīkstā | 0,25 mikrogrami | Alfacalcidolum |
A11CC03
|
20,12 |
I001092 |
Teva Pharma B.V., Nīderlande |
|
Rx |
Alpicort 2 mg/4 mg/ml uz ādas lietojams šķīdums |
Uz ādas lietojams šķīdums | 2 mg/4 mg/ml | Prednisolonum, Acidum salicylicum |
D07XA02
|
24,08 |
95-0182 |
Dr. August Wolff GmbH & Co. KG Arzneimittel, Vācija |
|
Rx |
Alpivab |
Koncentrāts infūziju šķīduma pagatavošanai | 200 mg | Peramivirum |
J05AH03
|
|
EU/1/18/1269/001 |
Biocryst Ireland Limited, Īrija |
|
Rx |
Alprazolam Orion 0,5 mg tabletes |
Tablete | 0,5 mg | Alprazolamum |
N05BA12
|
|
11-0076 |
Orion Corporation, Somija |
|
Rx KZSR |
Alprazolam Orion 1 mg tabletes |
Tablete | 1 mg | Alprazolamum |
N05BA12
|
6,05 |
11-0077 |
Orion Corporation, Somija |
|
Rx KZSR |
Alprazolam-Grindeks 0,25 mg tabletes |
Tablete | 0,25 mg | Alprazolamum |
N05BA12
|
2,76 |
00-1032 |
Grindeks, AS, Latvija |
|
Rx KZSR |
Alprazolam-Grindeks 0,5 mg tabletes |
Tablete | 0,5 mg | Alprazolamum |
N05BA12
|
4,55 |
00-1033 |
Grindeks, AS, Latvija |
|
Rx KZS |
Alprazolam-Grindeks 1 mg tabletes |
Tablete | 1 mg | Alprazolamum |
N05BA12
|
6,74 |
00-1034 |
Grindeks, AS, Latvija |
|
Rx |
Alprolix |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai | 250 SV | Eftrenonacogum alfa |
B02BD04
|
|
EU/1/16/1098/001 |
Swedish Orphan Biovitrum AB (publ), Zviedrija |
|
Rx |
Alprolix |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai | 500 SV | Eftrenonacogum alfa |
B02BD04
|
|
EU/1/16/1098/002 |
Swedish Orphan Biovitrum AB (publ), Zviedrija |
|
Rx |
Alprolix |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai | 1000 SV | Eftrenonacogum alfa |
B02BD04
|
|
EU/1/16/1098/003 |
Swedish Orphan Biovitrum AB (publ), Zviedrija |
|
Rx |
Alprolix |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai | 2000 SV | Eftrenonacogum alfa |
B02BD04
|
|
EU/1/16/1098/004 |
Swedish Orphan Biovitrum AB (publ), Zviedrija |
|
Rx |
Alprolix |
Pulveris un šķīdinātājs injekciju šķīduma pagatavošanai | 3000 SV | Eftrenonacogum alfa |
B02BD04
|
|
EU/1/16/1098/005 |
Swedish Orphan Biovitrum AB (publ), Zviedrija |
|
Rx |
Alyostal Prick |
Šķīdums ādas dūriena testam | 100 RI/ml;100 KI/ml vai 1000 KI/ml | Allergenum extractum |
V04CL
|
19,60 |
02-0154 |
Stallergenes, Francija |
|
Rx |
Alzepil 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg | Donepezili hydrochloridum |
N06DA02
|
|
09-0175 |
Egis Pharmaceuticals PLC, Ungārija |
|
Rx |
Alzepil 5 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg | Donepezili hydrochloridum |
N06DA02
|
|
09-0174 |
Egis Pharmaceuticals PLC, Ungārija |
|
Rx |
AmBisome liposomāls amfotericīns B 50 mg pulveris infūziju šķīduma pagatavošanai |
Pulveris infūziju šķīduma pagatavošanai | 50 mg | Amphotericinum B |
J02AA01
|
1992,38 |
01-0135 |
Gilead Sciences Ireland UC, Īrija |
|
Rx |
Aminoplasmal B.Braun 10% E šķīdums infūzijām |
Šķīdums infūzijām | 10% | Isoleucinum, Leucinum, Lysini hydrochloridum, Methioninum, Phenylalaninum, Threoninum, Tryptophanum, Valinum, Argininum, Histidinum, Alaninum, Glycinum, Acidum asparticum, Acidum glutamicum, Prolinum, Serinum, Tyrosinum, Natrii acetas trihydricus, Natrii hydroxidum, Kalii acetas, Magnesii chloridum hexahydricum, Dinatrii phosphas dodecahydricus |
B05BA10
|
|
05-0373 |
B.Braun Melsungen AG, Vācija |
|
Rx |
Aminoplasmal B.Braun 10% šķīdums infūzijām |
Šķīdums infūzijām | 10% | Isoleucinum, Leucinum, Lysini monohydricum, Lysini acetas, Methioninum, Phenylalaninum, Threoninum, Tryptophanum, Valinum, Argininum, Histidinum, Alaninum, Glycinum, Acidum asparticum, Acidum glutamicum, Prolinum, Serinum, Tyrosinum |
B05BA01
|
103,22 |
05-0374 |
B.Braun Melsungen AG, Vācija |
|
Rx |
Aminosteril N-Hepa 8% šķīdums infūzijām |
Šķīdums infūzijām | 8% | L-Histidinum, L-Isoleucinum, L-Leucinum, L-Lysini acetas, L-Methioninum, Acetylcysteinum, L-Phenylalaninum, L-Threoninum, L-Tryptophanum, L-Valinum, L-Argininum, Glycinum, L-Alaninum, L-Prolinum, L-Serinum, Acidum aceticum glaciale |
B05BA01
|
105,94 |
05-0371 |
Fresenius Kabi Deutschland GmbH, Vācija |
|
Rx KZS |
Amiptic 20 mg/5 mg/ml acu pilieni, šķīdums |
Acu pilieni, šķīdums | 20 mg/5 mg/ml | Dorzolamidum, Timololum |
S01ED51
|
9,84 |
13-0099 |
Pharmaceutical Works Polpharma SA, Polija |
|
Rx KZSR |
Amiptinon 20 mg/5 mg/ml acu pilieni, šķīdums |
Acu pilieni, šķīdums | 20 mg/5 mg/ml | Dorzolamidum, Timololum |
S01ED51
|
9,21 |
17-0150 |
Pharmaceutical Works Polpharma SA, Polija |
|
Rx KZSR |
Amitriptyline-Grindeks 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg | Amitriptylini hydrochloridum |
N06AA09
|
1,34 |
99-0474 |
Grindeks, AS, Latvija |
|
Rx KZSR |
Amitriptyline-Grindeks 25 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg | Amitriptylini hydrochloridum |
N06AA09
|
1,56 |
99-0092 |
Grindeks, AS, Latvija |
|
Rx KZS |
Amitriptylinum Meda 25 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg | Amitriptylini hydrochloridum |
N06AA09
|
1,96 |
96-0515 |
Meda Pharma, SIA, Latvija |
|
Rx KZSR |
Amlodipine Accord 10 mg tabletes |
Tablete | 10 mg | Amlodipinum |
C08CA01
|
1,34 |
12-0001 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Amlodipine Accord 5 mg tabletes |
Tablete | 5 mg | Amlodipinum |
C08CA01
|
0,69 |
12-0002 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Amlodipine Medochemie 10 mg tabletes |
Tablete | 10 mg | Amlodipinum |
C08CA01
|
7,12 |
07-0349 |
Medochemie Ltd., Kipra |
|
Rx |
Amlodipine Medochemie 5 mg tabletes |
Tablete | 5 mg | Amlodipinum |
C08CA01
|
4,54 |
07-0348 |
Medochemie Ltd., Kipra |
|
Rx |
Amlodipine Sopharma 10 mg tabletes |
Tablete | 10 mg | Amlodipinum |
C08CA01
|
|
16-0232 |
Sopharma AD, Bulgārija |
|
Rx |
Amlodipine Sopharma 5 mg tabletes |
Tablete | 5 mg | Amlodipinum |
C08CA01
|
|
16-0231 |
Sopharma AD, Bulgārija |
|
Rx |
Amlodipine Teva 10 mg tabletes |
Tablete | 10 mg | Amlodipinum |
C08CA01
|
1,72–4,17 |
08-0358 |
Teva Pharma B.V., Nīderlande |
|
Rx |
Amlodipine Teva 5 mg tabletes |
Tablete | 5 mg | Amlodipinum |
C08CA01
|
1,11–2,86 |
08-0357 |
Teva Pharma B.V., Nīderlande |
|
Rx KZS |
Amlodipine Vitabalans 10 mg tabletes |
Tablete | 10 mg | Amlodipinum |
C08CA01
|
2,15 |
11-0281 |
Vitabalans Oy, Somija |
|
Rx KZS |
Amlodipine Vitabalans 5 mg tabletes |
Tablete | 5 mg | Amlodipinum |
C08CA01
|
1,22 |
11-0280 |
Vitabalans Oy, Somija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/001 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/002 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/003 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/004 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/005 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/006 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/007 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/008 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/009 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/010 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/011 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/012 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/013 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/014 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/015 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/016 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/017 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/018 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/019 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/020 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/021 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/022 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/023 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/024 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/025 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/026 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/027 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/028 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/029 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/030 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/031 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/032 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/033 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/034 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/035 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/036 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/037 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/038 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Mylan |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
EU/1/16/1092/039 |
Mylan S.A.S, Francija |
|
Rx |
Amlodipine/Valsartan Sandoz 10 mg/160 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
16-0155 |
Sandoz d.d., Slovēnija |
|
Rx |
Amlodipine/Valsartan Sandoz 5 mg/160 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
16-0154 |
Sandoz d.d., Slovēnija |
|
Rx |
Amlodipine/Valsartan Sandoz 5 mg/80 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg/80 mg | Amlodipinum, Valsartanum |
C09DB01
|
|
16-0153 |
Sandoz d.d., Slovēnija |
|
Rx |
Amlodipine/Valsartan Teva 10 mg/160 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
13,18 |
16-0092 |
Teva B.V., Nīderlande |
|
Rx |
Amlodipine/Valsartan Teva 5 mg/160 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg/160 mg | Amlodipinum, Valsartanum |
C09DB01
|
11,74 |
16-0091 |
Teva B.V., Nīderlande |
|
Rx |
Ammonaps |
Tablete | 500 mg | Natrii phenylbutyras |
A16AX03
|
999,02 |
EU/1/99/120/001 |
Immedica Pharma AB, Zviedrija |
|
Rx |
Ammonaps |
Tablete | 500 mg | Natrii phenylbutyras |
A16AX03
|
|
EU/1/99/120/002 |
Immedica Pharma AB, Zviedrija |
|
Rx |
Ammonaps |
Granulas | 940 mg/g | Natrii phenylbutyras |
A16AX03
|
1703,28 |
EU/1/99/120/003 |
Immedica Pharma AB, Zviedrija |
|
Rx |
Ammonaps |
Granulas | 940 mg/g | Natrii phenylbutyras |
A16AX03
|
|
EU/1/99/120/004 |
Immedica Pharma AB, Zviedrija |
|
Rx |
Amoxicillin MIP 1000 mg tabletes |
Tablete | 1000 mg | Amoxicillinum |
J01CA04
|
|
12-0087 |
MIP Pharma GmbH, Vācija |
|
Rx |
Amoxicillin MIP 500 mg tabletes |
Tablete | 500 mg | Amoxicillinum |
J01CA04
|
|
12-0085 |
MIP Pharma GmbH, Vācija |
|
Rx KZS |
Ampril 10 mg tabletes |
Tablete | 10 mg | Ramiprilum |
C09AA05
|
5,56 |
05-0428 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Ampril 2,5 mg tabletes |
Tablete | 2,5 mg | Ramiprilum |
C09AA05
|
3,56 |
05-0426 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx KZS |
Ampril 5 mg tabletes |
Tablete | 5 mg | Ramiprilum |
C09AA05
|
2,92 |
05-0427 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx KZS |
Ampril HD 5 mg/25 mg tabletes |
Tablete | 5 mg/25 mg | Ramiprilum, Hydrochlorothiazidum |
C09BA05
|
8,50 |
05-0553 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Ampril HL 2,5 mg/12,5 mg tabletes |
Tablete | 2,5 mg/12,5 mg | Ramiprilum, Hydrochlorothiazidum |
C09BA05
|
5,03 |
05-0552 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Anagrelide AOP 0,5 mg cietās kapsulas |
Kapsula, cietā | 0,5 mg | Anagrelidum |
L01XX35
|
|
18-0070 |
AOP Orphan Pharmaceuticals AG, Austrija |
|
Rx KZS |
Anaprilīns 10 mg tabletes |
Tablete | 10 mg | Propranololi hydrochloridum |
C07AA05
|
3,44 |
95-0001 |
Olainfarm, AS, Latvija |
|
Rx KZS |
Anaprilīns 40 mg tabletes |
Tablete | 40 mg | Propranololi hydrochloridum |
C07AA05
|
5,39 |
00-0862 |
Olainfarm, AS, Latvija |
|
Rx |
Anoro Ellipta |
Inhalācijas pulveris, dozēts | 55 µg/22 µg | Umeclidinii bromidum, Vilanterolum |
R03AL03
|
|
EU/1/14/898/001 |
GlaxoSmithKline (Ireland) Limited, Īrija |
|
Rx KZS |
Anoro Ellipta |
Inhalācijas pulveris, dozēts | 55 µg/22 µg | Umeclidinii bromidum, Vilanterolum |
R03AL03
|
58,51 |
EU/1/14/898/002 |
GlaxoSmithKline (Ireland) Limited, Īrija |
|
Rx |
Anoro Ellipta |
Inhalācijas pulveris, dozēts | 55 µg/22 µg | Umeclidinii bromidum, Vilanterolum |
R03AL03
|
|
EU/1/14/898/003 |
GlaxoSmithKline (Ireland) Limited, Īrija |
|
OTC |
Anti-dispepsia tabletes |
Tablete | | Taraxaci officinalis radix, Carvi fructus, Menthae piperitae folium, Frangulae cortex, Silybi mariani extractum siccum raffinatum et normatum |
A16AX
|
2,79–6,60 |
99-0838 |
Pharmaceutical Laboratory Labofarm, Polija |
|
OTC |
Anuzol supozitoriji |
Supozitorijs | | Zinci sulfas, Belladonnae extractum, Xeroformium |
C05AX03
|
5,96 |
00-0196 |
AS Ņižfarm pārstāvniecība, Latvija |
|
Rx |
Apealea |
Pulveris infūziju šķīduma pagatavošanai | 60 mg | Paclitaxelum |
L01CD01
|
|
EU/1/18/1292/001 |
Oasmia Pharmaceutical AB, Zviedrija |
|
Rx |
Apel 600 mg apvalkotās tabletes |
Apvalkotā tablete | 600 mg | Linezolidum |
J01XX08
|
|
18-0158 |
Medochemie Ltd., Kipra |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/001 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/002 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/003 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/004 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/005 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/006 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/007 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx KZS |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
48,73 |
EU/1/04/285/008 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/009 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/010 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/011 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/012 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/013 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/014 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/015 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/016 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/017 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/018 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/019 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/020 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/021 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/022 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/023 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/024 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/025 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/026 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/027 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/028 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/029 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/030 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/031 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx KZS |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
48,73 |
EU/1/04/285/032 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/033 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/034 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/035 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
Apidra SoloStar |
Šķīdums injekcijām | 100 V/ml | Insulinum glulisinum |
A10AB06
|
|
EU/1/04/285/036 |
Sanofi-Aventis Deutschland GmbH, Vācija |
|
Rx |
APO-go PEN 10 mg/ml šķīdums injekcijām |
Šķīdums injekcijām | 10 mg/ml | Apomorphini hydrochloridum |
N04BC07
|
|
12-0060 |
Stada Arzneimittel AG, Vācija |
|
Rx |
Aponil 100 mg tabletes |
Tablete | 100 mg | Nimesulidum |
M01AX17
|
3,67–9,70 |
04-0208 |
Medochemie Ltd., Kipra |
|
Rx |
Apredonav 5 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg | Ivabradinum |
C01EB17
|
|
19-0012 |
Medochemie Ltd., Kipra |
|
Rx |
Apredonav 7,5 mg apvalkotās tabletes |
Apvalkotā tablete | 7,5 mg | Ivabradinum |
C01EB17
|
|
19-0013 |
Medochemie Ltd., Kipra |
|
Rx |
Aprepitant Sandoz 125 mg cietās kapsulas + Aprepitant Sandoz 80 mg cietās kapsulas |
Kapsula, cietā | 125 mg + 80 mg | Aprepitantum |
A04AD12
|
|
18-0011 |
Sandoz d.d., Slovēnija |
|
Rx |
Aprovel |
Tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/001 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/002 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/003 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/004 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/005 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/006 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/007 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/008 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/009 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/010 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/011 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/012 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/013 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/014 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/015 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/016 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/017 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/018 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/019 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/020 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/021 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
22,57 |
EU/1/97/046/022 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/023 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/024 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/025 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/026 |
Sanofi Clir SNC, Francija |
|
Rx KZS |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
32,48 |
EU/1/97/046/027 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/028 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/029 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/030 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/031 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/032 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/033 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/034 |
Sanofi Clir SNC, Francija |
|
Rx KZS |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
24,10 |
EU/1/97/046/035 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/036 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 75 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/037 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 150 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/038 |
Sanofi Clir SNC, Francija |
|
Rx |
Aprovel |
Apvalkotā tablete | 300 mg | Irbesartanum |
C09CA04
|
|
EU/1/97/046/039 |
Sanofi Clir SNC, Francija |
|
Rx KZS |
Aptivus |
Kapsula, mīkstā | 250 mg | Tipranavirum |
J05AE09
|
924,75 |
EU/1/05/315/001 |
Boehringer Ingelheim International GmbH, Vācija |
|
Rx |
Aptivus |
Šķīdums iekšķīgai lietošanai | 100 mg/ml | Tipranavirum |
J05AE09
|
|
EU/1/05/315/002 |
Boehringer Ingelheim International GmbH, Vācija |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/001 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/002 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/003 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/004 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/005 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/006 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/007 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/008 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/009 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/010 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/011 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/012 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/013 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/014 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/015 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/016 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/017 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/018 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/019 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/020 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/021 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/022 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/031 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/032 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/033 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/034 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/035 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/036 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/037 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/038 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/039 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/040 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/041 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/042 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/043 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/044 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/045 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/046 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/047 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/048 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/049 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/050 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/051 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/052 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/053 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/054 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/055 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/056 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/057 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/058 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/059 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/060 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/061 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/062 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/063 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/064 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/065 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/066 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/067 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/068 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/069 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/070 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/071 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/072 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/073 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/074 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 10 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/075 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/076 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 15 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/077 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/078 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 20 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/079 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
64,84 |
EU/1/01/185/080 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 30 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/081 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
85,78 |
EU/1/01/185/082 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/083 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/084 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 50 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/085 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
126,10 |
EU/1/01/185/086 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/087 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
166,41 |
EU/1/01/185/088 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 80 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/089 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
208,71 |
EU/1/01/185/090 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/091 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/092 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 130 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/093 |
Amgen Europe B.V., Nīderlande |
|
Rx KZSR |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
309,09 |
EU/1/01/185/094 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 150 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/095 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/096 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/097 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/098 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 500 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/099 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 25 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/100 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 25 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/101 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/102 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 40 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/103 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/104 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 60 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/105 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/106 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 100 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/107 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 200 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/108 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 200 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/109 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/110 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aranesp |
Šķīdums injekcijām | 300 μg | Darbepoetinum alfa |
B03XA02
|
|
EU/1/01/185/111 |
Amgen Europe B.V., Nīderlande |
|
Rx |
Aricept 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg | Donepezili hydrochloridum |
N06DA02
|
|
99-0135 |
Pfizer Europe MA EEIG, Beļģija |
|
Rx |
Aricept 5 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg | Donepezili hydrochloridum |
N06DA02
|
|
99-0134 |
Pfizer Europe MA EEIG, Beļģija |
|
Rx |
Arilin rapid 1000 mg pesāriji |
Pesārijs | 1000 mg | Metronidazolum |
G01AF01
|
10,40 |
00-0906 |
Dr. August Wolff GmbH & Co. KG Arzneimittel, Vācija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/001 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/002 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/003 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/004 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/005 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/006 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/007 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/008 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/009 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/010 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/011 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/012 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/013 |
Accord Healthcare S.L.U., Spānija |
|
Rx KZSR |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
17,33 |
EU/1/15/1045/014 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/015 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/016 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/017 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/018 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/019 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/020 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/021 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/022 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/023 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/024 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/025 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1045/026 |
Accord Healthcare S.L.U., Spānija |
|
Rx |
Aripiprazole Accord Healthcare 10 mg mutē disperģējamās tabletes |
Mutē disperģējamā tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
15-0222 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Aripiprazole Accord Healthcare 15 mg mutē disperģējamās tabletes |
Mutē disperģējamā tablete | 15 mg | Aripiprazolum |
N05AX12
|
34,10 |
15-0223 |
Accord Healthcare B.V., Nīderlande |
|
Rx |
Aripiprazole Mylan 10 mg tabletes |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
18-0057 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan 15 mg tabletes |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
18-0058 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/001 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/002 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/003 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/004 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/005 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/006 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/007 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
27,54 |
EU/1/15/1005/008 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/009 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/010 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/011 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/012 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/013 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/014 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/015 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/016 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/017 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
51,91 |
EU/1/15/1005/018 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/019 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole Mylan Pharma |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1005/020 |
Mylan S.A.S, Francija |
|
Rx |
Aripiprazole PMCS 10 mg tabletes |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
15-0234 |
PRO.MED.CS Praha a.s., Čehija |
|
Rx |
Aripiprazole PMCS 15 mg tabletes |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
15-0235 |
PRO.MED.CS Praha a.s., Čehija |
|
Rx |
Aripiprazole PMCS 5 mg tabletes |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
15-0233 |
PRO.MED.CS Praha a.s., Čehija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/001 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/002 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/003 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/004 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/005 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/006 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/007 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/008 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/009 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/010 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/011 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/012 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/013 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/014 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/015 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/016 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/017 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/018 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/019 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/020 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/021 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/022 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/023 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/024 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/025 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/026 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/027 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/028 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/029 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/030 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/031 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/032 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/033 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/034 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/035 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/036 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/037 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/038 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/039 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/040 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/041 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/042 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/043 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/044 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/045 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/046 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/047 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/048 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/049 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/050 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/051 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/052 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/053 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/054 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/055 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/056 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/057 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/058 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/059 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/060 |
Sandoz GmbH, Austrija |
|
Rx |
Aripiprazole Sandoz |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1029/061 |
Sandoz GmbH, Austrija |
|
Rx KZSR |
Aripiprazole Teva 15 mg tabletes |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
17,33 |
15-0061 |
Teva B.V., Nīderlande |
|
Rx |
Aripiprazole Zentiva |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/001 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/002 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/003 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/004 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/005 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/006 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/007 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/008 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/009 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/010 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/011 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
21,41 |
EU/1/15/1009/012 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/013 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/014 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/015 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/016 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/017 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/018 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/019 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/020 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/021 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/022 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 10 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/023 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/024 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/025 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 15 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/026 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/027 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/028 |
Zentiva, k.s., Čehija |
|
Rx |
Aripiprazole Zentiva |
Mutē disperģējamā tablete | 30 mg | Aripiprazolum |
N05AX12
|
|
EU/1/15/1009/029 |
Zentiva, k.s., Čehija |
|
Rx |
Arisppa 10 mg tabletes |
Tablete | 10 mg | Aripiprazolum |
N05AX12
|
8,86 |
15-0037 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx KZSR |
Arisppa 15 mg tabletes |
Tablete | 15 mg | Aripiprazolum |
N05AX12
|
17,33–38,70 |
15-0038 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Arisppa 20 mg tabletes |
Tablete | 20 mg | Aripiprazolum |
N05AX12
|
|
18-0089 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Arisppa 30 mg tabletes |
Tablete | 30 mg | Aripiprazolum |
N05AX12
|
38,30 |
15-0039 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Arisppa 5 mg tabletes |
Tablete | 5 mg | Aripiprazolum |
N05AX12
|
|
15-0036 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Arparial 25 mg/5 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg/5 mg | Metoprololi tartras, Ivabradinum |
C07FX05
|
|
15-0128 |
Les Laboratoires Servier, Francija |
|
Rx |
Arparial 25 mg/7,5 mg apvalkotās tabletes |
Apvalkotā tablete | 25 mg/7,5 mg | Metoprololi tartras, Ivabradinum |
C07FX05
|
|
15-0129 |
Les Laboratoires Servier, Francija |
|
Rx |
Arparial 50 mg/5 mg apvalkotās tabletes |
Apvalkotā tablete | 50 mg/5 mg | Metoprololi tartras, Ivabradinum |
C07FX05
|
|
15-0130 |
Les Laboratoires Servier, Francija |
|
Rx |
Arparial 50 mg/7,5 mg apvalkotās tabletes |
Apvalkotā tablete | 50 mg/7,5 mg | Metoprololi tartras, Ivabradinum |
C07FX05
|
|
15-0131 |
Les Laboratoires Servier, Francija |
|
Rx |
Arplexam 10 mg/2,5 mg/10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg/2,5 mg/10 mg | Perindoprili argininum, Indapamidum, Amlodipinum |
C09BX01
|
|
14-0055 |
Les Laboratoires Servier, Francija |
|
Rx |
Arplexam 10 mg/2,5 mg/5 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg/2,5 mg/5 mg | Perindoprili argininum, Indapamidum, Amlodipinum |
C09BX01
|
|
14-0054 |
Les Laboratoires Servier, Francija |
|
Rx |
Arplexam 5 mg/1,25 mg/10 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg/1,25 mg/10 mg | Perindoprili argininum, Indapamidum, Amlodipinum |
C09BX01
|
|
14-0053 |
Les Laboratoires Servier, Francija |
|
Rx |
Arplexam 5 mg/1,25 mg/5 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg/1,25 mg/5 mg | Perindoprili argininum, Indapamidum, Amlodipinum |
C09BX01
|
|
14-0052 |
Les Laboratoires Servier, Francija |
|
OTC |
Ascophen P tabletes |
Tablete | | Acidum acetylsalicylicum, Paracetamolum, Coffeinum |
N02BE51
|
0,74 |
98-0107 |
BRIZ, SIA, Latvija |
|
Rx |
Asparaginase medac 10 000 SV pulveris injekciju šķīduma pagatavošanai |
Pulveris injekciju šķīduma pagatavošanai | 10 000 SV | L-Asparaginasum |
L01XX02
|
|
03-0389 |
medac GmbH, Vācija |
|
Rx |
Asparaginase medac 5000 SV pulveris injekciju šķīduma pagatavošanai |
Pulveris injekciju šķīduma pagatavošanai | 5000 SV | L-Asparaginasum |
L01XX02
|
|
03-0388 |
medac GmbH, Vācija |
|
OTC |
Aspekard 100 mg tabletes |
Tablete | 100 mg | Acidum acetylsalicylicum |
B01AC06
|
|
00-0086 |
Stirolbiofarm Baltikum, SIA, Latvija |
|
OTC |
Aspirin 500 mg tabletes |
Tablete | 500 mg | Acidum acetylsalicylicum |
N02BA01
|
3,42–11,84 |
95-0312 |
UAB Bayer, Lietuva |
|
OTC |
Aspirin C 400 mg/240 mg putojošās tabletes |
Putojošā tablete | 400 mg/240 mg | Acidum acetylsalicylicum, Acidum ascorbicum |
N02BA51
|
5,30 |
98-0498 |
UAB Bayer, Lietuva |
|
OTC |
Aspirin Cardio 100 mg zarnās šķīstošās tabletes |
Zarnās šķīstošā tablete | 100 mg | Acidum acetylsalicylicum |
B01AC06
|
3,28–8,52 |
09-0345 |
UAB Bayer, Lietuva |
|
Rx KZS |
Atacand Plus 16 mg/12,5 mg tabletes |
Tablete | 16 mg/12,5 mg | Candesartanum cilexetilum, Hydrochlorothiazidum |
C09DA06
|
27,40 |
11-0413 |
AstraZeneca AB, Zviedrija |
|
Rx KZS |
Atordapin 10 mg + 10 mg apvalkotās tabletes |
Apvalkotā tablete | 10 mg + 10 mg | Amlodipinum, Atorvastatinum |
C10BX03
|
7,86 |
13-0059 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx KZS |
Atordapin 5 mg + 10 mg apvalkotās tabletes |
Apvalkotā tablete | 5 mg + 10 mg | Amlodipinum, Atorvastatinum |
C10BX03
|
6,32 |
14-0133 |
KRKA, d.d., Novo mesto, Slovēnija |
|
Rx |
Atosiban PharmIdea 37,5 mg/5 ml koncentrāts infūziju šķīduma pagatavošanai |
Koncentrāts infūziju šķīduma pagatavošanai | 37,5 mg/5 ml | Atosibanum |
G02CX01
|
44,96 |
16-0129 |
PharmIdea, SIA, Latvija |
|
Rx |
Atosiban PharmIdea 6,75 mg/0,9 ml šķīdums injekcijām |
Šķīdums injekcijām | 6,75 mg/0,9 ml | Atosibanum |
G02CX01
|
24,00 |
16-0128 |
PharmIdea, SIA, Latvija |
|
Rx |
Atripla |
Apvalkotā tablete | 600 mg/200 mg/245 mg | Efavirenzum, Emtricitabinum, Tenofovirum disoproxilum |
J05AR06
|
|
EU/1/07/430/001 |
Bristol-Myers Squibb and Gilead Sciences Limited, Īrija |
|
Rx |
Atripla |
Apvalkotā tablete | 600 mg/200 mg/245 mg | Efavirenzum, Emtricitabinum, Tenofovirum disoproxilum |
J05AR06
|
|
EU/1/07/430/002 |
Bristol-Myers Squibb and Gilead Sciences Limited, Īrija |
|
Rx |
Atropine Sopharma 1 mg/ml šķīdums injekcijām |
Šķīdums injekcijām | 1 mg/ml | Atropini sulfas |
A03BA01
|
7,92–64,48 |
05-0442 |
Sopharma AD, Bulgārija |
|
Rx KZS |
Azopt |
Acu pilieni, suspensija | 10 mg/ml | Brinzolamidum |
S01EC04
|
12,61 |
EU/1/00/129/001 |
Novartis Europharm Limited, Īrija |
|
Rx |
Azopt |
Acu pilieni, suspensija | 10 mg/ml | Brinzolamidum |
S01EC04
|
|
EU/1/00/129/002 |
Novartis Europharm Limited, Īrija |
|
|